A small panel of circulating biomarkers may reliably distinguish hypertrophic cardiomyopathy (HCM) from similar conditions that cause left ventricular hypertrophy (LVH), researchers found. From ...

The American College of Cardiology (ACC) and the American Heart Association (AHA) have released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy ...

The human heart is a muscle, but it’s also a kind of complicated balloon—a balloon that fills and empties roughly 60 to 100 times every minute, and several billion times during the course of a ...

Medically reviewed by Sameena Zahoor, MD Key Takeaways People with hypertrophic cardiomyopathy (HCM) have a higher risk of becoming severely ill from COVID-19.COVID-19 can cause heart damage and lead ...

MINNEAPOLIS — Readouts of data on an experimental drug for hypertrophic cardiomyopathies showed the agent appeared safe and effective in long-term treatment and can significantly improve exercise ...

Treatment sometimes involves an implantable defibrillator. Hypertrophic cardiomyopathy is the most common form of genetic heart disease worldwide. Researchers have estimated that up to 1 in 200 people ...

When medications arent doing enough to manage your hypertrophic cardiomyopathy (HCM), surgical procedures can offer real relief. HCM is a genetic heart condition in which parts of the heart muscle ...

Aficamten offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed aficamten's efficacy in improving exercise ...

Madrid, Spain – 30 August 2025. Mavacamten treatment at 48 weeks was not associated with significant improvements in patient-reported health status or peak oxygen consumption compared with placebo in ...

Experts released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM). The guideline reiterates the importance of collaborative ...